Lo: How Should Vaccines Be Financed?
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
This page contains recent media, interviews, and conference appearances by FSAS affiliated faculty and researchers
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
The Food Supply Chain Analytics and Sensing (FSAS) Initiative is creating predictive analytical tools and technologies to improve the design and management of safe and reliable food supply chains
By
Integrating robots into a manufacturing system is often prohibitively expensive. A new approach could change that.
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
Companies make common data science mistakes. Here’s an expert’s guide to what they are and how to avoid them.